2,172 research outputs found

    The Opacity of Spiral Galaxy Disks IV: Radial Extinction Profiles from Counts of Distant Galaxies seen through Foreground Disks

    Get PDF
    Dust extinction can be determined from the number of distant field galaxies seen through a spiral disk. To calibrate this number for the crowding and confusion introduced by the foreground image, Gonzalez et al.(1998) and Holwerda et al. (2005) developed the ``Synthetic Field Method'' (SFM), which analyses synthetic fields constructed by adding various deep exposures of unobstructed background fields to the candidate foreground galaxy field. The advantage of the SFM is that it gives the average opacity for area of galaxy disk without assumptions about either the distribution of absorbers or of the disk starlight. However it is limited by low statistics of the surviving field galaxies, hence the need to combine a larger sample of fields. This paper presents the first results for a sample of 32 deep HST/WFPC2 archival fields of 29 spirals. The radial profiles of average dust extinction in spiral galaxies based on calibrated counts of distant field galaxies is presented here, both for individual galaxies as well as for composites from our sample. The effects of inclination, spiral arms and Hubble type on the radial extinction profile are discussed. (Abbreviated)Comment: 43 pages, 16 figures, 3 tables, accepted for publication in the Astronomical Journal, (typos, table update, updates abstract

    UNAMBIGUOUS EVALUATIONS OF BIDECIC JACOBI AND JACOBSTHAL SUMS

    Get PDF
    Abstract For a class of primes p = 1 (mod 20) for which 2 is a quintic nonresidue, unambiguous evaluations of parameters of bidecic Jacobi and Jacobsthal sums (modp

    Reproducibility of coronary artery calcium quantification on dual-source CT and dual-source photon-counting CT:a dynamic phantom study

    Get PDF
    To systematically compare coronary artery calcium (CAC) quantification between conventional computed tomography (CT) and photon-counting CT (PCCT) at different virtual monoenergetic (monoE) levels for different heart rates. A dynamic (heart rates of 0,  75 bpm) anthropomorphic phantom with three calcification densities was scanned using routine clinical CAC protocols with CT and PCCT. In addition to the standard clinical protocol of 70 keV, PCCT images were reconstructed at monoE levels of 72, 74, and 76 keV. CAC was quantified using Agatston, volume, and mass scores. Agatston scores 95% confidence intervals (CI) were calculated and compared between PCCT and CT. Volume and mass scores were compared with physical quantities. For all CAC densities, routine clinical protocol Agatston scores of static CAC were higher for PCCT compared to CT. At < 60 bpm, Agatston scores at 74 and 76 keV reconstructions were reproducible (overlapping CI) for PCCT and CT. Increased heart rates yielded different Agatston scores for PCCT in comparison with CT, for all monoE levels. Low density CAC volume scores showed the largest deviation from physical volume, with mean deviations of 59% and 77% for CT and PCCT, respectively. Overall, mass scores underestimated physical mass by 10%, 38%, and 59% for low, medium, and high density CAC, respectively. PCCT allows for reproducible Agatston scores for dynamic CAC (< 60 bpm) when reconstructed at monoE levels of 74 or 76 keV, regardless of CAC density. Deviations from physical volume and mass were, in general, large for both CT and PCCT

    Experiences of case managers in providing person-centered and integrated care based on the Chronic Care Model:A qualitative study on embrace

    Get PDF
    <div><p>Background</p><p>Due to the rise in the number of older adults within the population, healthcare demands are changing drastically, all while healthcare expenditure continues to grow. Person-centered and integrated-care models are used to support the redesigning the provision of care and support. Little is known, however, about how redesigning healthcare delivery affects the professionals involved.</p><p>Objectives</p><p>To explore how district nurses and social workers experience their new professional roles as case managers within Embrace, a person-centered and integrated-care service for community-living older adults.</p><p>Methods</p><p>We performed a qualitative study consisting of in-depth interviews with case managers (district nurses, n = 6; social workers, n = 5), using a topic-based interview guide. Audiotaped interviews were transcribed verbatim and analyzed using qualitative content analysis.</p><p>Results</p><p>The experiences of the case managers involved four major themes: 1) the changing relationship with older adults, 2) establishing the case-manager role, 3) the case manager’s toolkit, and 4) the benefits of case management. Within these four themes, subthemes addressed the shift to a person-centered approach, building a relationship of trust, the process of case management, knowledge and experience, competencies of and requirements for case managers, and the differences in professional background.</p><p>Discussion</p><p>We found that this major change in role was experienced as a learning process, one that provided opportunities for personal and professional growth. Case managers felt that they were able to make a difference, and found their new roles satisfying and challenging, although stressful at times. Ongoing training and support were found to be a prerequisite in helping to shift the focus towards person-centered and integrated care.</p></div

    Nationwide Real-world Cohort Study of First-line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor-mutated Non-small-cell Lung Cancer

    Get PDF
    Most trials regarding tyrosine kinase inhibitors in patients with advanced epidermal growth factor receptor-mutated non-small-cell lung cancer comprised selected series from Asian populations. We found that Western European patients with epidermal growth factor receptor-mutated non-small-cell lung cancer who received first-line treatment with regular tyrosine kinase inhibitors have a median overall survival of 20.2 months in our large nationwide real-world cohort. In patients with brain metastasis, erlotinib showed superior results compared with gefitinib and was similar to afatinib. Background: Only a few randomized trials directly compared the relative efficacy of tyrosine kinase inhibitors (TKIs) in patients with advanced epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC), and most trials comprised selected series from Asian populations. Therefore, the aim of this study was to assess the overall survival (OS) of advanced EGFR-mutated NSCLC in a large white population and to evaluate variation between different TKIs and identify predictors of survival. Patients and Methods: Information about clinical characteristics, treatment, and survival for 873 patients with stage IV EGFR + NSCLC, diagnosed from 2015 through 2017, was derived from the Netherlands Cancer Registry. OS was evaluated by actuarial analysis and multivariable Cox regression. Prognostic factors are reported as hazard ratios and 95% confidence intervals. Results: A total of 596 (68%) patients received first-line treatment with regular TKIs, providing a median survival of 20.2 months. Forty-five percent of patients were 70 years and older, and 54% of patients had distant metastasis in multiple organs. In the multivariate analysis, survival was significantly worse for men, and patients with higher age, poorer performance, and >= 3 organs with metastasis. Compared with erlotinib, OS was worse for gefitinib users (adjusted hazard ratio, 1.30; 95% confidence interval, 1.02-1.64), predominantly in patients with brain metastasis. Conclusion: Dutch patients with EGFR-mutated NSCLC who received first-line treatment with regular TKIs have a median OS of 20.2 months in a nationwide real-world cohort. In patients with brain metastasis, erlotinib showed superior results compared with gefitinib and was similar to afatinib. (C) 2020 Elsevier Inc. All rights reserved

    NOx Emission Trends over Chinese Cities Estimated from OMI Observations During 2005 to 2015

    Get PDF
    Satellite NO2 observations have been widely used to evaluate emission changes. To determine trends in NOx emission over China, we used a method independent of chemical transport models to quantify the NOx emissions from 48 cities and 7 power plants over China, on the basis of Ozone Monitoring Instrument (OMI) NO2 observations during 2005 to 2015. We found that NOx emissions over 48 Chinese cities increased by 52 from 2005 to 2011 and decreased by 21 from 2011 to 2015. The decrease since 2011 could be mainly attributed to emission control measures in power sector; while cities with different dominant emission sources (i.e. power, industrial and transportation sectors) showed variable emission decline timelines that corresponded to the schedules for emission control in different sectors. The time series of the derived NOx emissions was consistent with the bottom-up emission inventories for all power plants (r = 0.8 on average), but not for some cities (r = 0.4 on average). The lack of consistency observed for cities was most probably due to the high uncertainty of bottom-up urban emissions used in this study, which were derived from downscaling the regional-based emission data to cities by using spatial distribution proxies

    Quantifying effects of radiotherapy-induced microvascular injury; review of established and emerging brain MRI techniques

    Get PDF
    Microvascular changes are increasingly recognised not only as primary drivers of radiotherapy treatment response in brain tumours, but also as an important contributor to short- and long-term (cognitive) side effects arising from irradiation of otherwise healthy brain tissue. As overall survival of patients with brain tumours is increasing, monitoring long-term sequels of radiotherapy-induced microvascular changes in the context of their potential predictive power for outcome, such as cognitive disability, has become increasingly relevant. Ideally, radiotherapy-induced significant microvascular changes in otherwise healthy brain tissue should be identified as early as possible to facilitate adaptive radiotherapy and to proactively start treatment to minimise the influence on these side-effects on the final outcome. Although MRI is already known to be able to detect significant long-term radiotherapy induced microvascular effects, more recently advanced MR imaging biomarkers reflecting microvascular integrity and function have been reported and might provide a more accurate and earlier detection of microvascular changes. However, the use and validation of both established and new techniques in the context of monitoring early and late radiotherapy-induced microvascular changes in both target-tissue and healthy tissue currently are minimal at best. This review aims to summarise the performance and limitations of existing methods and future opportunities for detection and quantification of radiotherapy-induced microvascular changes, as well as the relation of these findings with key clinical parameters. (C) 2019 Elsevier B.V. All rights reserved
    • …
    corecore